To this end, treatment of MCC cells with the HDAC inhibitor vorinostat in combination with the Sp1 inhibitor mithramycin A resulted in the transcription of the APM components followed by HLA class-I surface expression. Here, HDAC9 is linked to Merkel cell skin cancer.